Le informazioni sugli articoli di fonte ISI sono coperte da copyright

Per ulteriori informazioni selezionare i riferimenti di interesse.

1. Bornstein, NM
   Antiplatelet drugs: How to select them and possibilities of combined treatment
   CEREBROVASCULAR DISEASES
   
   N.M. Bornstein, "Antiplatelet drugs: How to select them and possibilities of combined treatment", CEREB DIS, 11, 2001, pp. 96-99
2. Fusman, R; Rotstein, R; Zeltser, D; Prochorov, V; Shapira, I; Bornstein, NM; Keren, G; Roth, A; Miller, HI; Avitzour, D; Arber, N; Berliner, S
   The state of leukocyte adhesiveness/aggregation in the peripheral blood ofpatients with type 2 diabetes and ischemic vascular disease
   ACTA DIABETOLOGICA
   
   R. Fusman et al., "The state of leukocyte adhesiveness/aggregation in the peripheral blood ofpatients with type 2 diabetes and ischemic vascular disease", ACT DIABETO, 38(1), 2001, pp. 43-49
3. Koton, S; Bornstein, NM; Green, MS
   Population group differences in trends in stroke mortality in Israel
   STROKE
   
   S. Koton et al., "Population group differences in trends in stroke mortality in Israel", STROKE, 32(9), 2001, pp. 1984-1988
4. Bornstein, NM; Aronovich, B; Korczyn, AD; Shavit, S; Michaelson, DM; Chapman, J
   Antibodies to brain antigens following stroke
   NEUROLOGY
   
   N.M. Bornstein et al., "Antibodies to brain antigens following stroke", NEUROLOGY, 56(4), 2001, pp. 529-530
5. Zeltser, D; Bornstein, NM; Rotstein, R; Shapira, I; Berliner, AS
   The erythrocyte adhesiveness/aggregation test in the peripheral blood of patients with ischemic brain events
   ACTA NEUROLOGICA SCANDINAVICA
   
   D. Zeltser et al., "The erythrocyte adhesiveness/aggregation test in the peripheral blood of patients with ischemic brain events", ACT NEUR SC, 103(5), 2001, pp. 316-319
6. Rotstein, R; Zeltser, D; Fusman, R; Shapira, I; Urbach, J; Bornstein, NM; Roth, A; Keren, G; Avitzour, D; Arber, N; Berliner, S
   The inflammation meter (INFLAMET): A new diagnostic approach to reveal thepresence of an inflammatory response and assess its intensity
   ISRAEL MEDICAL ASSOCIATION JOURNAL
   
   R. Rotstein et al., "The inflammation meter (INFLAMET): A new diagnostic approach to reveal thepresence of an inflammatory response and assess its intensity", ISR MED ASS, 2(6), 2000, pp. 476-477
7. Gur, AY; Bornstein, NM
   Are there any unique epidemiological and vascular risk factors for ischaemic strokes that occur in the morning hours?
   EUROPEAN JOURNAL OF NEUROLOGY
   
   A.Y. Gur e N.M. Bornstein, "Are there any unique epidemiological and vascular risk factors for ischaemic strokes that occur in the morning hours?", EUR J NEUR, 7(2), 2000, pp. 179-181
8. Wein, TH; Bornstein, NM
   Stroke prevention - Cardiac and carotid-related stroke
   NEUROLOGIC CLINICS
   
   T.H. Wein e N.M. Bornstein, "Stroke prevention - Cardiac and carotid-related stroke", NEUROL CLIN, 18(2), 2000, pp. 321
9. Kupferminc, MJ; Yair, D; Bornstein, NM; Lessing, JB; Elder, A
   Transient focal neurological deficits during pregnancy in carriers of inherited thrombophilia
   STROKE
   
   M.J. Kupferminc et al., "Transient focal neurological deficits during pregnancy in carriers of inherited thrombophilia", STROKE, 31(4), 2000, pp. 892-895
10. Bova, I; Sylantiev, C; Bornstein, NM; Chapman, J; Korczyn, AD
    Frequent polymorphism of the human methylenetetrahydrofolate reductase - Response
    STROKE
    
    I. Bova et al., "Frequent polymorphism of the human methylenetetrahydrofolate reductase - Response", STROKE, 31(4), 2000, pp. 990-990
11. Bova, I; Sylantiev, C; Bornstein, NM; Chapman, J; Korczyn, AD
    The A677V MTHFR allele is not associated with carotid atherosclerosis in octogenarians - Response
    STROKE
    
    I. Bova et al., "The A677V MTHFR allele is not associated with carotid atherosclerosis in octogenarians - Response", STROKE, 31(4), 2000, pp. 991-991
12. Berliner, S; Rogowski, O; Rotstein, R; Fusman, R; Shapira, I; Bornstein, NM; Prochorov, V; Roth, A; Keren, G; Eldor, A; Zeltser, D
    Activated polymorphonuclear leukocytes and monocytes in the peripheral blood of patients with ischemic heart and brain conditions correspond to the presence of multiple risk factors for atherothrombosis
    CARDIOLOGY
    
    S. Berliner et al., "Activated polymorphonuclear leukocytes and monocytes in the peripheral blood of patients with ischemic heart and brain conditions correspond to the presence of multiple risk factors for atherothrombosis", CARDIOLOGY, 94(1), 2000, pp. 19-25
13. Bornstein, NM
    Antiaggregants, old and new: which ones? In what cases? Mode of action
    PREVENTION OF ISCHEMIC STROKE
    
    N.M. Bornstein, "Antiaggregants, old and new: which ones? In what cases? Mode of action", PREVENTION OF ISCHEMIC STROKE, 2000, pp. 113-121
14. Bornstein, NM; Gur, AY; Fainshtein, P; Korczyn, AD
    Stroke during sleep: Epidemiological and clinical features
    CEREBROVASCULAR DISEASES
    
    N.M. Bornstein et al., "Stroke during sleep: Epidemiological and clinical features", CEREB DIS, 9(6), 1999, pp. 320-322
15. Bova, I; Chapman, J; Sylantiev, C; Korczyn, AD; Bornstein, NM
    The A677V methylenetetrahydrofolate reductase gene polymorphism and carotid atherosclerosis
    STROKE
    
    I. Bova et al., "The A677V methylenetetrahydrofolate reductase gene polymorphism and carotid atherosclerosis", STROKE, 30(10), 1999, pp. 2180-2182
16. Easton, JD; Diener, HC; Bornstein, NM; Einhaupl, K; Gent, M; Kaste, M; Sacco, RL; Tijssen, JGP; van Gijn, J
    Antiplatelet therapy: Views from the experts
    NEUROLOGY
    
    J.D. Easton et al., "Antiplatelet therapy: Views from the experts", NEUROLOGY, 53(7), 1999, pp. S32-S37
17. KAREPOV VG; HESS Y; BORNSTEIN NM; KORCZYN AD
    SMOKING REDUCES STROKE SEVERITY
    Annals of neurology
    
    V.G. Karepov et al., "SMOKING REDUCES STROKE SEVERITY", Annals of neurology, 44(3), 1998, pp. 112-112
18. CHAPMAN J; WANG NS; TREVES TA; KORCZYN AD; BORNSTEIN NM
    ACE, MTHFR, FACTOR-V-LEIDEN, AND APOE POLYMORPHISMS IN PATIENTS WITH VASCULAR AND ALZHEIMERS DEMENTIA
    Stroke
    
    J. Chapman et al., "ACE, MTHFR, FACTOR-V-LEIDEN, AND APOE POLYMORPHISMS IN PATIENTS WITH VASCULAR AND ALZHEIMERS DEMENTIA", Stroke, 29(7), 1998, pp. 1401-1404
19. KAREPOV VG; HASS Y; BORNSTEIN NM; KORCZYN AD
    SMOKING REDUCES STROKE SEVERITY
    Neurology
    
    V.G. Karepov et al., "SMOKING REDUCES STROKE SEVERITY", Neurology, 50(4), 1998, pp. 2087-2087
20. BORNSTEIN NM; GUR AY; SHIFRIN EG; MORAG BA
    DOES CAROTID ENDARTERECTOMY MODIFY CEREBRAL VASOMOTOR REACTIVITY
    Cerebrovascular diseases
    
    N.M. Bornstein et al., "DOES CAROTID ENDARTERECTOMY MODIFY CEREBRAL VASOMOTOR REACTIVITY", Cerebrovascular diseases, 7(4), 1997, pp. 201-204
21. TREVES TA; ARONOVICH BD; BORNSTEIN NM; KORCZYN AD
    RISK OF DEMENTIA AFTER A FIRST-EVER ISCHEMIC STROKE - A 3-YEAR LONGITUDINAL-STUDY
    Cerebrovascular diseases
    
    T.A. Treves et al., "RISK OF DEMENTIA AFTER A FIRST-EVER ISCHEMIC STROKE - A 3-YEAR LONGITUDINAL-STUDY", Cerebrovascular diseases, 7(1), 1997, pp. 48-52
22. KAREPOV VG; SITNOV I; TREVES TA; BORNSTEIN NM
    FACTORS WHICH INFLUENCE IN-HOSPITAL MORTALITY AFTER ACUTE ISCHEMIC STROKE
    Stroke
    
    V.G. Karepov et al., "FACTORS WHICH INFLUENCE IN-HOSPITAL MORTALITY AFTER ACUTE ISCHEMIC STROKE", Stroke, 28(1), 1997, pp. 38-38
23. BORNSTEIN NM; CHAPMAN J; WANG NS; ASHEROV A; TREVES TA; KORCZYN AD
    GENETIC RISK-FACTORS FOR VASCULAR DEMENTIA
    Stroke
    
    N.M. Bornstein et al., "GENETIC RISK-FACTORS FOR VASCULAR DEMENTIA", Stroke, 28(1), 1997, pp. 176-176
24. BORNSTEIN NM; BOVA IY; KORCZYN AD
    INFECTIONS AS TRIGGERING FACTORS FOR ISCHEMIC STROKE
    Neurology
    
    N.M. Bornstein et al., "INFECTIONS AS TRIGGERING FACTORS FOR ISCHEMIC STROKE", Neurology, 49(5), 1997, pp. 45-46
25. ELAD B; BORNSTEIN NM; KORCZYN AD
    MECHANICAL VENTILATION - REPLY
    Neurology
    
    B. Elad et al., "MECHANICAL VENTILATION - REPLY", Neurology, 49(1), 1997, pp. 311-312
26. NEUFELD MY; VISHNEVSKAYA S; TREVES TA; REIDER I; KAREPOV V; BORNSTEIN NM; KORCZYN AD
    PERIODIC LATERALIZED EPILEPTIFORM DISCHARGES (PLEDS) FOLLOWING STROKEARE ASSOCIATED WITH METABOLIC ABNORMALITIES
    Electroencephalography and clinical neurophysiology
    
    M.Y. Neufeld et al., "PERIODIC LATERALIZED EPILEPTIFORM DISCHARGES (PLEDS) FOLLOWING STROKEARE ASSOCIATED WITH METABOLIC ABNORMALITIES", Electroencephalography and clinical neurophysiology, 102(4), 1997, pp. 295-298
27. KAREPOV V; BORNSTEIN NM; HASS Y; KORCZYN AD
    DOES DAILY ASPIRIN DIMINISH SEVERITY OF FIRST-EVER STROKE
    Archives of neurology
    
    V. Karepov et al., "DOES DAILY ASPIRIN DIMINISH SEVERITY OF FIRST-EVER STROKE", Archives of neurology, 54(11), 1997, pp. 1369-1371
28. TREVES TA; CHAPMAN J; BORNSTEIN NM; VERCHOVSKY R; ASHEROV A; VESHCHEV IO; KLIMOVITZKI S; KORCZYN AD
    APOE-EPSILON-4 IN AGE-RELATED MEMORY COMPLAINTS AND ALZHEIMERS-DISEASE
    European journal of neurology
    
    T.A. Treves et al., "APOE-EPSILON-4 IN AGE-RELATED MEMORY COMPLAINTS AND ALZHEIMERS-DISEASE", European journal of neurology, 3(6), 1996, pp. 515-518
29. TREVES TA; BORNSTEIN NM; CHAPMAN J; KLIMOVITZKI S; VERCHOVSKY R; ASHEROV A; VESHCHEV IO; KORCZYN AD
    APOE-EPSILON-4 IN PATIENTS WITH ALZHEIMER-DISEASE AND VASCULAR DEMENTIA
    Alzheimer disease and associated disorders
    
    T.A. Treves et al., "APOE-EPSILON-4 IN PATIENTS WITH ALZHEIMER-DISEASE AND VASCULAR DEMENTIA", Alzheimer disease and associated disorders, 10(4), 1996, pp. 189-191
30. BORNSTEIN NM; GUR AY; TREVES TA; REIDERGROSWASSER I; ARONOVICH BD; KLIMOVITZKY SS; VARSSANO D; KORCZYN AD
    DO SILENT BRAIN INFARCTIONS PREDICT THE DEVELOPMENT OF DEMENTIA AFTERFIRST ISCHEMIC STROKE
    Stroke
    
    N.M. Bornstein et al., "DO SILENT BRAIN INFARCTIONS PREDICT THE DEVELOPMENT OF DEMENTIA AFTERFIRST ISCHEMIC STROKE", Stroke, 27(5), 1996, pp. 904-905
31. GUR A; BORNSTEIN NM
    BILATERAL SEVERE CAROTID STENOSIS - IS STROKE UNAVOIDABLE
    Stroke
    
    A. Gur e N.M. Bornstein, "BILATERAL SEVERE CAROTID STENOSIS - IS STROKE UNAVOIDABLE", Stroke, 27(4), 1996, pp. 794-794
32. GUR AY; BOVA I; BORNSTEIN NM
    IS IMPAIRED CEREBRAL VASOMOTOR REACTIVITY A PREDICTIVE FACTOR OF STROKE IN ASYMPTOMATIC PATIENTS
    Stroke
    
    A.Y. Gur et al., "IS IMPAIRED CEREBRAL VASOMOTOR REACTIVITY A PREDICTIVE FACTOR OF STROKE IN ASYMPTOMATIC PATIENTS", Stroke, 27(12), 1996, pp. 2188-2190
33. BOVA IY; BORNSTEIN NM; KORCZYN AD
    ACUTE INFECTION AS A RISK FACTOR FOR ISCHEMIC STROKE
    Stroke
    
    I.Y. Bova et al., "ACUTE INFECTION AS A RISK FACTOR FOR ISCHEMIC STROKE", Stroke, 27(12), 1996, pp. 2204-2206
34. BORNSTEIN NM; ARONOVICH BD; KAREPOV VG; GUR AY; TREVES TA; OVED M; KORCZYN AD
    THE TEL-AVIV-STROKE-REGISTRY - 3600 CONSECUTIVE PATIENTS
    Stroke
    
    N.M. Bornstein et al., "THE TEL-AVIV-STROKE-REGISTRY - 3600 CONSECUTIVE PATIENTS", Stroke, 27(10), 1996, pp. 1770-1773
35. KAREPOV VG; BORNSTEIN NM; HASS Y; KORCZYN AD
    DOES THE PROFILE OF RISK-FACTORS OF STROKE INFLUENCE ASPIRIN FAILURE
    Stroke
    
    V.G. Karepov et al., "DOES THE PROFILE OF RISK-FACTORS OF STROKE INFLUENCE ASPIRIN FAILURE", Stroke, 27(1), 1996, pp. 25-25
36. ELAD B; BORNSTEIN NM; FUCHS P; KORCZYN AD
    MECHANICAL VENTILATION IN STROKE PATIENTS - IS IT WORTHWHILE
    Neurology
    
    B. Elad et al., "MECHANICAL VENTILATION IN STROKE PATIENTS - IS IT WORTHWHILE", Neurology, 47(3), 1996, pp. 657-659
37. KAREPOV VG; BORNSTEIN NM; HASS Y; KORCZYN AD
    WHAT FACTORS ARE RESPONSIBLE FOR ASPIRIN FAILURE
    Neurology
    
    V.G. Karepov et al., "WHAT FACTORS ARE RESPONSIBLE FOR ASPIRIN FAILURE", Neurology, 46(2), 1996, pp. 3097-3097
38. BORNSTEIN NM; GUR AY; TREVES TA; GROSWASSER I; ARONOVICH BD; KORCZYN AD
    ARE SILENT BRAIN INFARCTS PREDICTIVE OF VASCULAR DEMENTIA
    Neurology
    
    N.M. Bornstein et al., "ARE SILENT BRAIN INFARCTS PREDICTIVE OF VASCULAR DEMENTIA", Neurology, 46(2), 1996, pp. 5108-5108
39. SHIFRIN EG; BORNSTEIN NM; KANTAROVSKY A; MORAG B; ZELMANOVICH L; PORTNOI I; ARONOVICH B
    CAROTID ENDARTERECTOMY WITHOUT ANGIOGRAPHY
    British Journal of Surgery
    
    E.G. Shifrin et al., "CAROTID ENDARTERECTOMY WITHOUT ANGIOGRAPHY", British Journal of Surgery, 83(8), 1996, pp. 1107-1109
40. BORNSTEIN NM; GUR AY; SHIFRIN EG; MORAG BA; KORCZYN AD
    DOES CAROTID ENDARTERECTOMY MODIFY CEREBROVASCULAR REACTIVITY
    Stroke
    
    N.M. Bornstein et al., "DOES CAROTID ENDARTERECTOMY MODIFY CEREBROVASCULAR REACTIVITY", Stroke, 26(4), 1995, pp. 724-724
41. KOUDSTAAL PJ; VANLATUM JC; VANGIJN J; KAPPELLE LJ; ALGRA A; DEHAENE I; DHOOGHE M; MARCHAU M; VANZANDIJCKE M; DELWAIDE C; DEPRE A; LATERRE EC; VANBUGGENHOUT E; SCHURMANS J; DESMET E; SWERTS L; VANDENABEELE G; CARTON H; VERDRU PMA; INDEKEU PA; LAM D; VANDENBERGH V; MOL L; VANLANDEGEM W; STRAUVEN T; BOYSEN G; GYRING J; PETERSEN P; WURTZENNIELSEN P; CREPINLEBLOND T; MOULIN T; AURIACOMBE S; ORGOGOZO JM; BOULLIAT J; GOAS JY; MOCQUARD Y; BESSON G; HOMMEL M; ADNETBONTE C; JOSIEN E; PETIT H; CHEDRU F; EVRARD S; LEVASSEUR M; MAS JL; MEYNIARD O; ZUBER M; AMARENCO P; BOUSSER MG; ROULLET E; PINEL JF; MASSARDIER E; MIHOUT B; CHOLLET F; RASCOL A; AUTRET A; SAUNDEAU D; BUTTNER T; NIEMCZYK W; BOHM KD; HORNIG C; HACKE W; HEISS C; REUTHER R; HAASS A; STOLL M; KRAMER G; ROTHACHER G; BAUER M; BUSSE O; KOCHROSE S; MUEFFELMANN B; DICHGANS J; THOMAS C; HENNEN OAD; JORG J; SCHWAN H; SIEPEN R; BORNSTEIN NM; CENSORI B; CERAVOLO M; PROVINCIALI L; DALESSANDRO G; BOTTACCHI E; CARENINI L; DUC E; FEDERICO F; FIORE A; LAMBERTI P; LATTANZI P; CAMERLINGO M; CASTO L; MAMOLI A; BENEMIO G; BOLDRINI F; GATTESCHI C; SCHILLACI G; VERDECCHIA P; VIGNAI E; ARCELLI G; BRAVI S; COLI L; GIRELLI L; PURRO A; DELFAVERO C; GUIDOTTI M; PELLEGRINI G; SANTARONE M; TADEO G; BOTTINI G; CANEPARI C; STERZI R; BINDA A; CANDELISE L; NADOR F; PINARDI G; OLIVA L; MOMBELLONI A; PONARI O; SQUERI M; BARZIZZA F; CAVALLINI A; MICIELI G; NAPPI G; RICHICHI I; CASELLI P; MORETTI E; AISA G; BOSCHETTI E; CAPUTO N; CELANI MG; DELFAVERO A; NENCI G; RICCI S; RIGHETTI E; SENIN U; BIOTTI M; DETTORE M; FABRIZI G; GRASSELLI S; PEZZELLA F; ANTONUTTI L; GRANDI FC; GUERRINI D; MARZALLI A; PINAMONTI B; SALVI R; SAMMARTINI C; DUDINE P; MILONE FF; VICENZI M; TERBERG JWM; GELMERS HJ; HAAS JA; LINDEBOOM SF; HERDERSCHEE D; HIJDRA A; VERMEULEN M; BERTELSMANN FW; HAZENBERG GJ; KOETSIER JC; BERNTSEN PJIM; GEBBINK TB; SLEEGERS FM; VANBEECK JA; FEIKEMA WJ; VANGASTEREN JHM; VELTEMA AN; VREDEVELD CJM; CARBAAT PAT; HERTZBERGER LI; KLEYWEG RP; BOON AM; LIEUWENS WHG; VISSCHER F; ARTS WFM; BOON A; MOLL LCM; PERQUIN WVM; TANS JTJ; TONK R; DEWEERD AW; HAAXMAREICHE H; OOSTERHUIS HJGH; SNOEK JW; FRANKE CL; MIRANDOLLE JF; KOEHLER PJJ; BRIET PE; VANROSSUM J; BOITEN J; BOON AE; LODDER J; NIHOM J; MAUSER HW; FRENKEN CWGM; POELS EFJ; PRICK MJJ; VERHAGEN WIM; HOPPENBROUWERS WJJF; STAAL A; BENEDER PR; BULENS C; DEVRIESBOS LHP; DECOUL AAWO; LEYTEN ACM; TIJSSEN CC; SCHELLENS RLLA; CILLESSEN JPM; DRIESEN JJM; VANOUDENAARDEN WF; VERHEY JCB; FRISVOLD OJ; HOLE T; SKOGEN OR; ASLAKSEN B; GALLEFOSS F; LAAKE KO; BERG LK; BALSLIEMKE S; RITLAND S; HVEEM K; DEHLI O; ABILDGAARD U; DAHL T; WELUND B; GONCALVES JAG; PALMEIRO JF; AMARAL R; MACHADO C; MESTRE A; RIBEIRO F; SOUSA L; SALGADO AV; BAPTISTA A; CANDIDO JM; MORGADO AV; RAMIRES IMV; CRESPO M; FERRO JM; FRANCO AS; MELO TMP; OLIVEIRA V; LIMA AFB; CORREIA MM; LOPEZ JC; MORGADO R; SANTOS M; GRAU G; LOPEZ J; MARTIN R; MATIASGUIU J; ALIO J; CALOPA M; MIRALLES F; RUBIO F; FUEYO J; GOMEZ C; MOLINA L; DOLHABERRIAGUE L; SOLERSINGLA L; DAVALOS A; GENIS D; BASSAGANYAS J; BARREIRO P; DIEZTEJEDOR E; FRANK A; COSTA J; MARES R; LAINEZ L; SANCHO J; HENNERDAL KH; RUDBACK N; SAMUELSON M; SIGFRIDSON P; HEDENUS M; BOGOUSSLAVSKY J; GHIKA J; MARIANI L; NATER B; SCHMID F; KNIGHT R; HAMILTON SJC; KANE J; BELL R; FOOTE CK; CASSIDY T; GRAY CS; SANDERCOCK PAG; SELLAR R; WARLOW CP; HOWE JG; MCGOURTY JC; BAMFORD J; JOHNSON M; CASTLEDEN CM; HARPER GD; PANAYIOTOU BN; ROBINSON T; BARER D; HUMPHREY P; KAFETZ K; MCELLIGOTT G; BATES D; CARTLIDGE NEF; VENABLES GS; MONRO P
    OPTIMAL ORAL ANTICOAGULANT-THERAPY IN PATIENTS WITH NONRHEUMATIC ATRIAL-FIBRILLATION AND RECENT CEREBRAL-ISCHEMIA
    The New England journal of medicine
    
    P.J. Koudstaal et al., "OPTIMAL ORAL ANTICOAGULANT-THERAPY IN PATIENTS WITH NONRHEUMATIC ATRIAL-FIBRILLATION AND RECENT CEREBRAL-ISCHEMIA", The New England journal of medicine, 333(1), 1995, pp. 5-10
42. KAREPOV VG; BORNSTEIN NM; HASS Y; TREVES TA; KORCZYN AD
    ASPIRIN PRETREATMENT DOES NOT DIMINISH THE SEVERITY OF 1ST-EVER ISCHEMIC STROKE
    Neurology
    
    V.G. Karepov et al., "ASPIRIN PRETREATMENT DOES NOT DIMINISH THE SEVERITY OF 1ST-EVER ISCHEMIC STROKE", Neurology, 45(4), 1995, pp. 241-241
43. REIDERGROSWASSER I; BORNSTEIN NM; KORCZYN AD
    PARKINSONISM IN PATIENTS WITH LACUNAR INFARCTS OF THE BASAL GANGLIA
    European neurology
    
    I. Reidergroswasser et al., "PARKINSONISM IN PATIENTS WITH LACUNAR INFARCTS OF THE BASAL GANGLIA", European neurology, 35(1), 1995, pp. 46-49
44. NORRIS JW; BLACK SE; BORNSTEIN NM; KRAJEWSKI A; LEBRUN LH; DANEAULT N; ANDERSON BA; BOWYER B; GLADISH D; DESROCHERS MP; MUKERJEE J; DEPOT M
    INTRAVENOUS NIMODIPINE IN ACUTE ISCHEMIC STROKE (VOL 4, PG 194, 1994)
    Cerebrovascular diseases
    
    J.W. Norris et al., "INTRAVENOUS NIMODIPINE IN ACUTE ISCHEMIC STROKE (VOL 4, PG 194, 1994)", Cerebrovascular diseases, 4(5), 1994, pp. 353-353
45. BORNSTEIN NM
    LIFE-STYLE CHANGES - SMOKING, ALCOHOL, DIET AND EXERCISE
    Cerebrovascular diseases
    
    N.M. Bornstein, "LIFE-STYLE CHANGES - SMOKING, ALCOHOL, DIET AND EXERCISE", Cerebrovascular diseases, 4(2), 1994, pp. 59-65
46. BORNSTEIN NM
    NEW CONCEPTS IN STROKE PATHOPHYSIOLOGY AND PREVENTION - SANOFI-WINTHROP SYMPOSIUM 2ND INTERNATIONAL STROKE CONFERENCE GENEVA, SWITZERLAND MAY 13, 1993 - OPENING REMARKS
    Cerebrovascular diseases
    
    N.M. Bornstein, "NEW CONCEPTS IN STROKE PATHOPHYSIOLOGY AND PREVENTION - SANOFI-WINTHROP SYMPOSIUM 2ND INTERNATIONAL STROKE CONFERENCE GENEVA, SWITZERLAND MAY 13, 1993 - OPENING REMARKS", Cerebrovascular diseases, 4, 1994, pp. 1-1
47. INZELBERG R; BORNSTEIN NM; REIDER I; KORCZYN AD
    BASAL GANGLIA LACUNES AND PARKINSONISM
    Neuroepidemiology
    
    R. Inzelberg et al., "BASAL GANGLIA LACUNES AND PARKINSONISM", Neuroepidemiology, 13(3), 1994, pp. 108-112
48. TREVES TA; BORNSTEIN NM; KAREPOV VG; KORCZYN AD
    FACTORS ASSOCIATED WITH FAILURE OF ASPIRIN TREATMENT - RESPONSE
    Stroke
    
    T.A. Treves et al., "FACTORS ASSOCIATED WITH FAILURE OF ASPIRIN TREATMENT - RESPONSE", Stroke, 25(8), 1994, pp. 1702-1702
49. TREVES TA; BORNSTEIN NM
    ASPIRIN IN ELDERLY ATRIAL-FIBRILLATION PATIENTS - RESPONSE
    Stroke
    
    T.A. Treves e N.M. Bornstein, "ASPIRIN IN ELDERLY ATRIAL-FIBRILLATION PATIENTS - RESPONSE", Stroke, 25(7), 1994, pp. 1526-1526
50. TREVES TA; KAREPOV VG; ARONOVICH BD; GORBULEV AY; BORNSTEIN NM; KORCZYN AD
    INTERRATER AGREEMENT IN EVALUATION OF STROKE PATIENTS WITH THE UNIFIED NEUROLOGICAL STROKE SCALE
    Stroke
    
    T.A. Treves et al., "INTERRATER AGREEMENT IN EVALUATION OF STROKE PATIENTS WITH THE UNIFIED NEUROLOGICAL STROKE SCALE", Stroke, 25(6), 1994, pp. 1263-1264
51. BORNSTEIN NM; KAREPOV VG; ARONOVICH BD; GORBULEV AY; TREVES TA; KORCZYN AD
    FAILURE OF ASPIRIN TREATMENT AFTER STROKE
    Stroke
    
    N.M. Bornstein et al., "FAILURE OF ASPIRIN TREATMENT AFTER STROKE", Stroke, 25(2), 1994, pp. 275-277
52. BORNSTEIN NM; KAREPOV VG; ARONOVICH BD; GORBULEV AY; KORCZYN AD
    ASPIRIN TREATMENT AND SEVERITY OF RECURRENT STROKE
    Stroke
    
    N.M. Bornstein et al., "ASPIRIN TREATMENT AND SEVERITY OF RECURRENT STROKE", Stroke, 25(1), 1994, pp. 268-268
53. FUCHS P; ELAD B; BORNSTEIN NM; KORCZYN AD
    MECHANICAL VENTILATION IN PATIENTS WITH ISCHEMIC STROKE - IS IT WORTHWHILE
    Neurology
    
    P. Fuchs et al., "MECHANICAL VENTILATION IN PATIENTS WITH ISCHEMIC STROKE - IS IT WORTHWHILE", Neurology, 44(4), 1994, pp. 10000129-10000129
54. GORBULEV AY; NEUFELD MY; TREVES TA; ARONOVICH BD; BORNSTEIN NM; KORCZYN AD
    EEG AS PREDICTOR OF DEMENTIA FOLLOWING FIRST ISCHEMIC CEREBRAL STROKE
    Neurology
    
    A.Y. Gorbulev et al., "EEG AS PREDICTOR OF DEMENTIA FOLLOWING FIRST ISCHEMIC CEREBRAL STROKE", Neurology, 44(4), 1994, pp. 10000173-10000173
55. ARONOVICH BD; CHAPMAN J; SHAVIT S; BORNSTEIN NM; KORCZYN AD
    ANTIBRAIN ANTIBODIES - A MARKER FOR TISSUE-DAMAGE IN STROKE
    Neurology
    
    B.D. Aronovich et al., "ANTIBRAIN ANTIBODIES - A MARKER FOR TISSUE-DAMAGE IN STROKE", Neurology, 44(4), 1994, pp. 10000192-10000192
56. KAREPOV VG; BORNSTEIN NM; ARONOVICH BD; GORBULEV AY; KORCZYN AD
    ASPIRIN TREATMENT AND SEVERITY OF RECURRENT STROKE
    Neurology
    
    V.G. Karepov et al., "ASPIRIN TREATMENT AND SEVERITY OF RECURRENT STROKE", Neurology, 44(4), 1994, pp. 10000271-10000271
57. BORNSTEIN NM; KAREPOV VG; ARONOVICH BD; GORBULEV AY; TREVES TA; KORCZYN AD
    FAILURE OF ASPIRIN TREATMENT AFTER STROKE
    Neurology
    
    N.M. Bornstein et al., "FAILURE OF ASPIRIN TREATMENT AFTER STROKE", Neurology, 44(4), 1994, pp. 10000288-10000288
58. BORNSTEIN NM; NORRIS JW
    TRANSCRANIAL DOPPLER SONOGRAPHY IS AT PRESENT OF LIMITED CLINICAL-VALUE
    Archives of neurology
    
    N.M. Bornstein e J.W. Norris, "TRANSCRANIAL DOPPLER SONOGRAPHY IS AT PRESENT OF LIMITED CLINICAL-VALUE", Archives of neurology, 51(10), 1994, pp. 1057-1059
59. GUR AY; NEUFELD MY; TREVES TA; ARONOVICH BD; BORNSTEIN NM; KORCZYN AD
    EEG AS PREDICTOR OF DEMENTIA FOLLOWING FIRST ISCHEMIC STROKE
    Acta neurologica Scandinavica
    
    A.Y. Gur et al., "EEG AS PREDICTOR OF DEMENTIA FOLLOWING FIRST ISCHEMIC STROKE", Acta neurologica Scandinavica, 90(4), 1994, pp. 263-265
60. BORNSTEIN NM; NORRIS JW
    EVOLUTION AND MANAGEMENT OF ASYMPTOMATIC CAROTID STENOSIS
    Cerebrovascular and brain metabolism reviews
    
    N.M. Bornstein e J.W. Norris, "EVOLUTION AND MANAGEMENT OF ASYMPTOMATIC CAROTID STENOSIS", Cerebrovascular and brain metabolism reviews, 5(4), 1993, pp. 301-313
61. COPPERMAN Y; BORNSTEIN NM; NISSEL T; LANIADO S
    THE USE OF TRANSCRANIAL DOPPLER IN THE HEMODYNAMIC ASSESSMENT OF IMPLANTED PACEMAKERS
    PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY
    
    Y. Copperman et al., "THE USE OF TRANSCRANIAL DOPPLER IN THE HEMODYNAMIC ASSESSMENT OF IMPLANTED PACEMAKERS", PACE, 16(12), 1993, pp. 2217-2221
62. KOUDSTAAL PJ; DEHAENE I; DHOOGHE M; MARCHAU M; VANZANDIJCKE M; DELWAIDE C; DEPRE A; LATERRE EC; VANBUGGENHOUT E; SCHURMANS J; DESMET E; SWERTS L; VANDENABEELE G; CARTON H; VERDRU PMA; INDEKEU PA; LAM D; VANDENBERGH V; VANLANDEGEM W; STRAUVEN T; BOYSEN G; GYRING J; PETERSEN P; WURTZENNIELSEN P; CREPINLEBLOND T; MOULIN T; AURIACOMBE S; ORGOGOZO JM; BOULLIAT J; GOAS JY; MOCQUARD Y; BESSON G; HOMMEL M; ADNETBONTE C; JOSIEN E; CHEDRU F; EVRARD S; LEVASSEUR M; MAS JL; MEYNIARD O; ZUBER M; AMARENCO P; BOUSSER MG; ROULLET E; PINEL JF; MASSARDIER E; MIHOUT B; CHOLLET F; RASCOL A; AUTRET A; SAUDEAU D; BUTTNER T; NIEMCZYK W; BOHM KD; HORNIG C; HACKE W; HEISS C; REUTHER R; HAASS A; STOLL M; KRAMER G; ROTHACHER G; BAUER M; BUSSE O; KOCHROSE S; MUEFFELMANN B; DICHGANS J; THOMAS C; HENNEN OAD; JORG J; SCHWAN H; SIEPEN R; BORNSTEIN NM; CENSORI B; CERAVOLO M; PROVINCIALI L; DALESSANDRO G; BOTTACCHI E; CARENINI L; DUC E; FEDERICO F; FIORE A; LAMBERTI P; LATTANZI P; CAMERLINGO M; CASTO L; MAMOLI A; BENEMIO G; BOLDRINI F; GATTESCHI C; SCHILLACI G; VERDECCHIA P; VIGNAI E; ARCELLI G; BRAVI S; COLI L; GIRELLI L; PURRO A; DELFAVERO C; GUIDOTTI M; PELLEGRINI G; SANTARONE M; TADEO G; BOTTINI G; CANEPARI C; STERZI R; BINDA A; CANDELISE L; NADOR F; PINARDI G; OLIVA L; MOMBELLONI A; PONARI O; SQUERI M; BARZIZZA F; CAVALLINI A; MICIELI G; NAPPI G; RICHICHI I; CASELLI P; MORETTI E; AISA G; BOSCHETTI E; CAPUTO N; CELANI MG; DELFAVERO A; NENCI G; RICCI S; RIGHETTI E; SENIN U; BIOTTI M; DETTORE M; FABRIZI G; GRASSELLI S; PEZZELLA F; ANTONUTTI L; GRANDI FC; GUERRINI D; MARZALLI A; PINAMONTI B; SALVI R; SAMMARTINI C; DUDINE P; MILONE FF; VICENZI M; TERBERG JWM; GELMERS HJ; HAAS JA; LINDEBOOM SF; HERDERSCHEE D; HIJDRA A; VERMEULEN M; BERTELSMANN FW; HAZENBERG GJ; KOETSIER JC; BERNTSEN PJIM; GEBBINK TB; SLEEGERS FM; VANBEECK JA; FEIKEMA WJ; VANGASTEREN JHM; VELTEMA AN; VREDEVELD CJM; CARBAAT PAT; HERTZBERGER LI; KLEYWEG RP; BOON AM; LIEUWENS WHG; VISSCHER F; ARTS WFM; BOON A; MOLL LCM; PERQUIN WVM; TANS JTJ; TONK R; DEWEERD AW; HAAXMAREICHE H; OOSTERHUIS HJGH; SNOEK JW; FRANKE CL; MIRANDOLLE JF; KOEHLER PJJ; BRIET PE; VANROSSUM J; BOITEN J; BOON AE; LODDER J; NIHOM J; MAUSER HW; FRENKEN CWGM; POELS EFJ; PRICK MJJ; VERHAGEN WIM; HOPPENBROUWERS WJJF; KOUUDSTAAL PJ; STAAL A; BENEDER PR; BULENS C; DEVRIESBOS LHP; DECOUL AAWO; LEYTEN ACM; TIJSSEN CC; SCHELLENS RLLA; CILLESSEN JPM; VANGIJN J; KAPPELLE LJ; DRIESEN JJM; VANOUDENAARDEN WF; VERHEY JCB; FRISVOLD OJ; HOLE T; SKOGEN OR; ASLAKSEN B; GALLEFOSS F; LAAKE KO; BERG LK; BALSLIEMKE S; RITLAND S; HVEEM K; DEHLI O; ABILDGAARD U; DAHL T; WELUND; GONCALVES JAG; MAIA R; PALMEIRO JF; AMARAL R; MACHADO C; MESTRE A; RIBEIRO F; SOUSA L; SALGADO AV; BAPTISTA A; CANDIDO JM; MORGADO AV; RAMIRES IMV; CRESPO M; FERRO JM; FRANCO AS; MELO TMP; OLIVEIRA V; LIMA AFB; CORREIA MM; LOPEZ JC; MORGADO R; SANTOS M; GRAU G; LOPEZ J; MARTIN R; MATIASGUIU J; ALIO J; CALOPA M; MIRALLES F; RUBIO F; FUEYO J; GOMEZ C; MOLINA L; DOLHABERRIAGUE L; SOLERSINGLA L; DAVALOS A; GENIS D; BASSAGANYAS J; BARREIRO P; DIEZTEJEDOR E; FRANK A; COSTA J; MARES R; LAINEZ L; SANCHO J; HENNERDAL KH; RUDBACK N; SAMUELSSON M; SIGFRIDSON P; HEDENUS M; BOGOUSSLAVSKY J; GHIKA J; MARIANI L; NATER B; SCHMID F; KNIGHT R; HAMILTON SJC; KANE J; BELL R; FOOTE CK; CASSIDY T; GRAY CS; SANDERCOCK PAG; SELLAR R; WARLOW CP; HOWE JG; MCGOURTY JC; BAMFORD J; JOHNSON M; CASTLEDEN CM; HARPER GD; PANAYIOTOU BN; ROBINSON T; BARER D; HUMPHREY P; KAFETZ K; MCELLIGOTT G; BATES D; CARTLIDGE NEF; VENABLES GS; MONRO P; VANLATUM JC; VERMEULEN PC; DENOUDEN A; MAST B; KOUDSTAAL PJ; BOGOUSSLAVSKY J; BOYSEN G; BORNSTEIN N; CANDELISE L; DAHL T; DEHAENE I; FERRO J; VANGIJN J; GUSTAFSSON C; HEDENUS M; HIJDRA A; KOUDSTAAL PJ; KRAMER G; LODDER J; MAS JL; MATIASGUIU J; RICCI S; SANDERCOCK PAG; SCHOBBEN AFAM; STAAL A; VENABLES GS; VERMEULEN M; COLLINS R; HARRISON MJG; HILL C; ALGRA A; BAARSMA GS; BANGA JD; BROWER RW; KAPPELLE LJ; LOELIGER EA; LUBSEN J; POP GAM; VANSWIETEN JC; TIJSSEN JGP; VANURK H; VERHEUGT FWA
    SECONDARY PREVENTION IN NONRHEUMATIC ATRIAL-FIBRILLATION AFTER TRANSIENT ISCHEMIC ATTACK OR MINOR STROKE
    Lancet
    
    P.J. Koudstaal et al., "SECONDARY PREVENTION IN NONRHEUMATIC ATRIAL-FIBRILLATION AFTER TRANSIENT ISCHEMIC ATTACK OR MINOR STROKE", Lancet, 342(8882), 1993, pp. 1255-1262